Results 211 to 220 of about 32,129 (220)

Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients

Cancer, 2007
Stephanie Williams, Jane Winter, Martin Tallman   +2 more
exaly  

Identifying factors affecting the pharmacokinetics of voriconazole in patients with liver dysfunction: A population pharmacokinetic approach

Basic and Clinical Pharmacology and Toxicology, 2019
Miao Yan, Ping Xu, Bi-Kui Zhang
exaly  

Influence of different proton pump inhibitors on the pharmacokinetics of voriconazole

International Journal of Antimicrobial Agents, 2017
Liqin Zhu, Gaoqi Xu
exaly  

Risk Factors for Voriconazole Hepatotoxicity at 12 Weeks in Lung Transplant Recipients

American Journal of Transplantation, 2012
Seyed M Hosseini-Moghaddam, Lianne G Singer, Cecilia Chaparro   +2 more
exaly  

Voriconazole

Reactions Weekly, 2012
openaire   +1 more source

Adverse effects of voriconazole: Over a decade of use

Clinical Transplantation, 2016
Pranatharthi H Chandrasekar
exaly  

Saturated Metabolism of Voriconazole <i>N</i>-Oxidation Resulting in Nonlinearity of Pharmacokinetics of Voriconazole at Clinical Doses

Biological and Pharmaceutical Bulletin, 2015
Yasuaki Mino, Tatsuya Yagi, Takafumi Naito   +2 more
exaly  

Voriconazole-Associated Cutaneous Malignancy: A Literature Review on Photocarcinogenesis in Organ Transplant Recipients

Clinical Infectious Diseases, 2014
Peter Chin-Hong, Jonathan P Singer, Sarah T Arron   +2 more
exaly  

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

Lancet, The, 2005
Bart Jan Kullberg, C Viscoli, P G Pappas   +2 more
exaly  

The pharmacokinetics and safety of intravenous voriconazole - a novel wide-spectrum antifungal agent

British Journal of Clinical Pharmacology, 2003
Lynn Purkins, Nolan Wood
exaly